REMSIMA SC

Celltrion Inc🇨🇦 Health Canada

Approval Id: 4e1ec7fa76c31ae5
Drug Approval Canada Name: REMSIMA SC
Product Name: REMSIMA SC
Status: Marketed
Status Date: 2024-06-28
Original Market Date: 2021-06-04
Din: 02511584
Drug Class: Human
Dosage Form: Kit , Solution
Route Of Administration: Subcutaneous
Schedule: Prescription , Schedule D
Ahfs: 90:24.16.92
Atc Original: L04AB02 INFLIXIMAB
Atc Name: l 04 ab 02
Aig Number: 0144162002
Company Name: Celltrion Inc
Company Address: 23 Academy-Ro, Yeonsu-Gu, Incheon, --, Korea, Republic Of, 22014
Company Detail Path: /organization/celltrion-inc

INFLIXIMAB

120 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

4e1ec7fa76c31ae5

Type

Standard